{"id":52755,"date":"2023-01-10T15:02:54","date_gmt":"2023-01-10T14:02:54","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/alsac-names-ericka-debruce-chief-diversity-equity-inclusion-and-belonging-officer\/"},"modified":"2023-01-10T15:02:54","modified_gmt":"2023-01-10T14:02:54","slug":"alsac-names-ericka-debruce-chief-diversity-equity-inclusion-and-belonging-officer","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/alsac-names-ericka-debruce-chief-diversity-equity-inclusion-and-belonging-officer\/","title":{"rendered":"ALSAC names Ericka DeBruce chief diversity, equity, inclusion and belonging officer"},"content":{"rendered":"
\n

\nReginald Porter Jr. assumes key role in relational development<\/i>\n<\/p>\n

MEMPHIS, Tenn.–(BUSINESS WIRE)–ALSAC<\/a>, the fundraising and awareness organization for St. Jude Children’s Research Hospital\u00ae<\/sup><\/a> <\/sup>, has announced the appointment of Ericka DeBruce to the role of senior vice president, chief diversity, equity, inclusion and belonging officer. DeBruce succeeds Reginald Porter Jr. who has been named senior vice president, relational development and social responsibility. Porter is now leading efforts to engage key donors in support of the St. Jude mission while continuing to spearhead ALSAC\u2019s work to positively impact the communities where its employees live and work as well as partners\u2019 corporate social responsibility practices.\n<\/p>\n

<\/a>
<\/a><\/p>\n

\nDeBruce will be building upon established programs, including ALSAC\u2019s Business Resource Groups, and spearheading strategic initiatives to ensure ALSAC is a culturally competent and inclusive organization that promotes diversity of thought, background and experiences for employees, patient families and supporters.\n<\/p>\n

\n\u201cALSAC and St. Jude were founded on the ideals of a diverse, inclusive and equitable world, and that remains at the core of our DNA,\u201d said Richard C. Shadyac Jr<\/a>., president and CEO of ALSAC. \u201cI witnessed Ericka\u2019s passion and deep subject matter expertise firsthand when she trained our team in the past, and we are incredibly fortunate she has joined us full-time to continue efforts to foster open, honest dialogue and collaborations which are imperative to our success and true to our founding principles.\n<\/p>\n

\nDeBruce has nearly two decades of experience leading diversity, equity, inclusion and belonging efforts at global Fortune 500 companies, nonprofits and other organizations. Her proven record of success in creating organizational cultures that leverage individual differences and value equal opportunity for all includes recognition for Unum<\/a> as one of Forbes America’s Best Employers for Diversity while she served as its chief inclusion and diversity officer.\n<\/p>\n

\n“Joining the ALSAC team is a full-circle, career moment for me,\u201d said DeBruce. \u201cOne of my first positions was working for a sibling charity overseeing a program focused on diversifying the blood supply to assist children with sickle cell disease. While in that role, I learned about the vital research and treatment methods that St. Jude provided to children and hospitals around the world, never imagining I would someday have the honor to lead diversity initiatives for the fundraising and awareness organization for the institution.\u201d\n<\/p>\n

\nThe addition of DeBruce as a leading industry expert brings new opportunities for ALSAC to continue to advance an inclusive and equitable environment for employees, patient families, supporters and members of the communities the organization serves.\n<\/p>\n

\nSt. Jude Children\u2019s Research Hospital\u00ae<\/sup><\/b>\n<\/p>\n

\nSt. Jude Children\u2019s Research Hospital is leading the way the world understands, treats and defeats childhood cancer and other life-threatening diseases. Its purpose is clear: Finding cures. Saving children.\u00ae<\/sup> It is the only National Cancer Institute-designated Comprehensive Cancer Center devoted solely to children. When St. Jude opened in 1962, childhood cancer was considered incurable. Since then, St. Jude has helped push the overall survival rate from 20% to more than 80%, and it won’t stop until no child dies from cancer. St. Jude shares the breakthroughs it makes to help doctors and researchers at local hospitals and cancer centers around the world improve the quality of treatment and care for even more children. Because of generous donors, families never receive a bill from St. Jude for treatment, travel, housing or food, so they can focus on helping their child live. Visit St. Jude Inspire<\/a> to discover powerful St. Jude stories of hope, strength, love and kindness. Support the St. Jude mission by donating at stjude.org<\/a>, liking St. Jude on Facebook<\/a>, following St. Jude on Twitter<\/a>, Instagram<\/a>, LinkedIn<\/a> and TikTok<\/a>, and subscribing to its YouTube<\/a> channel.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nmediarelations@alsac.stjude.org<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Reginald Porter Jr. assumes key role in relational development MEMPHIS, Tenn.–(BUSINESS WIRE)–ALSAC, the fundraising and awareness organization for St. Jude Children’s Research Hospital\u00ae , has announced the appointment of Ericka DeBruce to the role of senior vice president, chief diversity, equity, inclusion and belonging officer. DeBruce succeeds Reginald Porter Jr. who has been named senior … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-52755","6":"format-standard","7":"category-industry"},"yoast_head":"\nALSAC names Ericka DeBruce chief diversity, equity, inclusion and belonging officer - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/alsac-names-ericka-debruce-chief-diversity-equity-inclusion-and-belonging-officer\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ALSAC names Ericka DeBruce chief diversity, equity, inclusion and belonging officer - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Reginald Porter Jr. assumes key role in relational development MEMPHIS, Tenn.–(BUSINESS WIRE)–ALSAC, the fundraising and awareness organization for St. Jude Children’s Research Hospital\u00ae , has announced the appointment of Ericka DeBruce to the role of senior vice president, chief diversity, equity, inclusion and belonging officer. DeBruce succeeds Reginald Porter Jr. who has been named senior ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/alsac-names-ericka-debruce-chief-diversity-equity-inclusion-and-belonging-officer\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-01-10T14:02:54+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230110005037\/en\/1679429\/21\/Ericka_DeBruce_Headshot.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/alsac-names-ericka-debruce-chief-diversity-equity-inclusion-and-belonging-officer\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/alsac-names-ericka-debruce-chief-diversity-equity-inclusion-and-belonging-officer\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"ALSAC names Ericka DeBruce chief diversity, equity, inclusion and belonging officer\",\"datePublished\":\"2023-01-10T14:02:54+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/alsac-names-ericka-debruce-chief-diversity-equity-inclusion-and-belonging-officer\\\/\"},\"wordCount\":627,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/alsac-names-ericka-debruce-chief-diversity-equity-inclusion-and-belonging-officer\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230110005037\\\/en\\\/1679429\\\/21\\\/Ericka_DeBruce_Headshot.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/alsac-names-ericka-debruce-chief-diversity-equity-inclusion-and-belonging-officer\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/alsac-names-ericka-debruce-chief-diversity-equity-inclusion-and-belonging-officer\\\/\",\"name\":\"ALSAC names Ericka DeBruce chief diversity, equity, inclusion and belonging officer - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/alsac-names-ericka-debruce-chief-diversity-equity-inclusion-and-belonging-officer\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/alsac-names-ericka-debruce-chief-diversity-equity-inclusion-and-belonging-officer\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230110005037\\\/en\\\/1679429\\\/21\\\/Ericka_DeBruce_Headshot.jpg\",\"datePublished\":\"2023-01-10T14:02:54+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/alsac-names-ericka-debruce-chief-diversity-equity-inclusion-and-belonging-officer\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/alsac-names-ericka-debruce-chief-diversity-equity-inclusion-and-belonging-officer\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/alsac-names-ericka-debruce-chief-diversity-equity-inclusion-and-belonging-officer\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230110005037\\\/en\\\/1679429\\\/21\\\/Ericka_DeBruce_Headshot.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230110005037\\\/en\\\/1679429\\\/21\\\/Ericka_DeBruce_Headshot.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/alsac-names-ericka-debruce-chief-diversity-equity-inclusion-and-belonging-officer\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ALSAC names Ericka DeBruce chief diversity, equity, inclusion and belonging officer\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ALSAC names Ericka DeBruce chief diversity, equity, inclusion and belonging officer - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/alsac-names-ericka-debruce-chief-diversity-equity-inclusion-and-belonging-officer\/","og_locale":"en_US","og_type":"article","og_title":"ALSAC names Ericka DeBruce chief diversity, equity, inclusion and belonging officer - Pharma Trend","og_description":"Reginald Porter Jr. assumes key role in relational development MEMPHIS, Tenn.–(BUSINESS WIRE)–ALSAC, the fundraising and awareness organization for St. Jude Children’s Research Hospital\u00ae , has announced the appointment of Ericka DeBruce to the role of senior vice president, chief diversity, equity, inclusion and belonging officer. DeBruce succeeds Reginald Porter Jr. who has been named senior ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/alsac-names-ericka-debruce-chief-diversity-equity-inclusion-and-belonging-officer\/","og_site_name":"Pharma Trend","article_published_time":"2023-01-10T14:02:54+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230110005037\/en\/1679429\/21\/Ericka_DeBruce_Headshot.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/alsac-names-ericka-debruce-chief-diversity-equity-inclusion-and-belonging-officer\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/alsac-names-ericka-debruce-chief-diversity-equity-inclusion-and-belonging-officer\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"ALSAC names Ericka DeBruce chief diversity, equity, inclusion and belonging officer","datePublished":"2023-01-10T14:02:54+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/alsac-names-ericka-debruce-chief-diversity-equity-inclusion-and-belonging-officer\/"},"wordCount":627,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/alsac-names-ericka-debruce-chief-diversity-equity-inclusion-and-belonging-officer\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230110005037\/en\/1679429\/21\/Ericka_DeBruce_Headshot.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/alsac-names-ericka-debruce-chief-diversity-equity-inclusion-and-belonging-officer\/","url":"https:\/\/pharma-trend.com\/en\/alsac-names-ericka-debruce-chief-diversity-equity-inclusion-and-belonging-officer\/","name":"ALSAC names Ericka DeBruce chief diversity, equity, inclusion and belonging officer - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/alsac-names-ericka-debruce-chief-diversity-equity-inclusion-and-belonging-officer\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/alsac-names-ericka-debruce-chief-diversity-equity-inclusion-and-belonging-officer\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230110005037\/en\/1679429\/21\/Ericka_DeBruce_Headshot.jpg","datePublished":"2023-01-10T14:02:54+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/alsac-names-ericka-debruce-chief-diversity-equity-inclusion-and-belonging-officer\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/alsac-names-ericka-debruce-chief-diversity-equity-inclusion-and-belonging-officer\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/alsac-names-ericka-debruce-chief-diversity-equity-inclusion-and-belonging-officer\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230110005037\/en\/1679429\/21\/Ericka_DeBruce_Headshot.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230110005037\/en\/1679429\/21\/Ericka_DeBruce_Headshot.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/alsac-names-ericka-debruce-chief-diversity-equity-inclusion-and-belonging-officer\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"ALSAC names Ericka DeBruce chief diversity, equity, inclusion and belonging officer"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/52755","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=52755"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/52755\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=52755"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=52755"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=52755"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}